Neurology - Page 5

Registered on ClinicalTrials

Results of an international multicenter, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of sequential therapy with ethylmethylhydroxypyridine succinate in patients in the acute and early recovery periods of ischemic stroke (IS)

The results of a cohort -center randomized study of the modulating effect of Mexidol® in the rehabilitation of patients who have undergone acute cerebral failure

The value of mitochondrial dysfunction in stabilization

The results of a multicenter dual blind randomized placebo-controlled clinical study on the assessment of the effectiveness and safety of the drug Mexidol in the treatment of attention deficit syndrome in children (mega)

The results of an international multicenter randomized double-blind-controlled study of evaluating the effectiveness of the effectiveness and safety of consistent therapy of patients with chronic brain ischemia with Mexidol and Mexidol Forte 250 (study of Memo)

The results of a randomized double blind multicenter placebo-controlled in parallel groups of the study and safety of Mexidol with prolonged consistent therapy in patients in the acute and early recovery periods

The results of a cohort -center randomized study of the modulating effect of Mexidol® in the rehabilitation of patients who have undergone acute cerebral failure

The value of mitochondrial dysfunction in stabilization

The effect of the use of Mexidol during the "therapeutic window" of ischemic stroke on the effectiveness of intravenous thrombolytic therapy

Authors:
K.S. KNNI, T.V. DEMIN, L.B. ADEEVA

GAUZ "Interregional Clinical and Diagnostic Center", Kazan, Russia

The effect of mexidol on changes in the lipid-phospholipid profile in acute cerebrovascular accidents in elderly patients

Author:
Yu. V. ABRAMENKO

FSBEI in the Tver State Medical University of the Ministry of Health of Russia, Tver, Russia

The experience of using Mexidol in neurological practice

Authors:

O.A. GROMOVA¹, I.Yu. TORSHIN¹, L.V. STAKHOVSKAYA², E.G. Pepelyaev³, V.A. SEMENOV³, A.G. NAZARENKO⁴

¹Institute of Pharmacoinformatics, Federal Research Center "Information Science and Control" of the Russian Academy of Sciences, Moscow, Russia;
²Research Institute of Cerebrovascular Pathology and Stroke, N.I. Pirogov Russian National Research Medical University, Moscow, Russia;
³Kemerovo State Medical University, Kemerovo, Russia;
⁴Burdenko National Medical Research Center of Neurosurgery, Moscow, Russia

The effectiveness of Mexidol with transient ischemic attacks in the vertebral-baslar system in elderly patients with chronic brain ischemia

Author:
Yu. V. ABRAMENKO

FSBEI in the Tver State Medical University of the Ministry of Health of Russia, Tver, Russia

Mono- and combination therapy with Mexidol in young patients with cerebral angiodystonia

Authors:
E.N. DYAKONOVA, V.V. MAKEROVA

Federal State Budgetary Educational Institution of Higher Education "Ivanovo State Medical Academy" of the Ministry of Health of the Russian Federation, Ivanovo, Russia

Improving the effectiveness of treatment of hypertensive encephalopathy with the drug Mexidol

Authors:
E.V. BOLOTOVA¹, T.Yu. LUSHPAY², I.V. KOVRIGINA²

¹Federal State Budgetary Educational Institution of Higher Education “Kuban State Medical University” of the Ministry of Health of the Russian Federation, Krasnodar, Russia;
²State Budgetary Healthcare Institution “Research Institute — Regional Clinical Hospital No. 1 named after Professor S.V. Ochapovsky” of the Ministry of Health of Krasnodar Krai, Krasnodar, Russia

The effect of submaximal doses of Mexidol on oxidative stress and inflammation processes in the acute period of ischemic stroke

Authors:
A.R. GODUNOVA, A.A. Rakhimova, O.I. LEONTIEV, I.G. TALIPOVA, R.M. YAKHIN, Sh.G. MUSIN

State Budgetary Healthcare Institution of the Republic of Tatarstan “Emergency Hospital”, Naberezhnye Chelny, Russia

Treatment of dizziness in elderly patients with chronic cerebrovascular pathology

Author:
S.N. DUMA

Research Institute of Therapy and Preventive Medicine-a branch of the Federal State University "Federal Research Center Institute of Cytology and Genetics of the Siberian Branch of the Russian Academy of Sciences", Novosibirsk, Russia

The results of a randomized double blind multicenter placebo-controlled in parallel groups of the study and safety of Mexidol with prolonged consistent therapy in patients in acute and early restorations. Periods

Authors:
L.V. STAKHOVSKAYA¹, N.A. SHAMALOV¹, D.R. KHASANOVA², E.V. MELNIKOVA³, A.S. AGAFINA⁴, K.V. GOLIKOV⁵, E.I. BOGDANOV⁶, A.A. YAKUPOVA⁶, L.V. ROSHKOVSKA⁷, L.V. LUKINYKH⁸, T.M. LOKSHTANOVA⁹, I.E. Poverennova¹⁰, L.A. SCHEPANKEVICH¹¹

¹Research Institute of Cerebrovascular Pathology and Stroke, Pirogov Russian National Research Medical University, Moscow, Russia;
²Interregional Clinical and Diagnostic Center, Kazan, Russia;
³St. Petersburg City Hospital No. 26, St. Petersburg, Russia;
⁴St. Petersburg City Hospital No. 40 of the Kurortny Administrative District, St. Petersburg, Russia;
⁵St. Petersburg City Multidisciplinary Hospital No. 2, St. Petersburg, Russia;
⁶Kazan State Medical University, Kazan, Russia;
⁷St. Petersburg Nikolaevskaya Hospital, St. Petersburg, Russia;
⁸Vsevolozhsk Clinical Interdistrict Hospital, Leningrad Region, Russia.
⁹MUBZ City Clinical Hospital No. 1 named after N.I. Pirogov, Samara, Russia;
¹⁰State Budgetary Healthcare Institution Samara Regional Clinical Hospital named after V.D. Seredavin, Samara, Russia;
¹¹Federal State Budgetary Scientific Institution Research Institute of Experimental and Clinical Medicine, Novosibirsk, Russia.

Modern protection strategies for hypoxic-itchemic brain damage

Authors:

Yanishevsky S.N.*, Tsygan N.V., Golokhvastov S.Yu. , Andreev R.V., Litvinenko I.V. , Karpova O.S., Yakovleva V.A.

*FSBVOU in "Military Medical Academy named after CM. Kirov ”, St. Petersburg, Russia

Place of publication:

Journal of Neurology and Psychiatry, 12, 2017

Features of anxiety manifestation in older patients with different types of mild cognitive impairment

Author:

Sidenkova A.P.

Federal State Budgetary Educational Institution of Higher Education "Ural State Medical University" of the Ministry of Health of the Russian Federation, Yekaterinburg, Russia

Place of publication:

JOURNAL OF NEUROLOGY AND PSYCHIATRY, 11, 2017

Dodemic cognitive disorder. Directions of therapy

Author:

Sokolova L.P.

Place of publication:

Neuronyus, issue No. 11 (37) 2017

Modern approaches to neuroprotective therapy of ischemic stroke

Authors:

STAKHOVSKAYA L.V.*1, TYUTYUMOVA E.A.2*, FEDIN A.I.*2

1*Research Institute of Cerebrovascular Pathology and Stroke,
N.I. Pirogov Russian National Research Medical University, Ministry of Health of the Russian Federation, Moscow, Russia;

2*Federal State Budgetary Educational Institution of Higher Education “N.I. Pirogov Russian National Research Medical University” of the Ministry of Health of the Russian Federation, Moscow, Russia

Place of publication:

JOURNAL OF NEUROLOGY AND PSYCHIATRY, 8, 2017

Morphofunctional bases of the development of vascular cognitive and emotional disorders

Author:

Zhitkova Yu.V.

Place of publication:

Neurology, neuropsychiatry, psychosomatics. 2017

Modern criteria for rational diagnosis and treatment of cerebrovascular diseases

Authors:

BUTAKOVA Y.S., ZHIVOLUPOV S.A., SAMARTSEV I.N.

Place of publication:

Neuronyus, issue No. 10 (36) October 2017

Modern paradigm of rational therapy of strokes

Zhivolupov S.A., Butakova Yu.S., Samartsev I.N.

Department of Nervous Diseases of the Military Medical Academy; Primary vascular branch of the Novodvinsk City Hospital, St. Petersburg, Russia

Place of publication:

Journal of Neurology and Psychiatry, 8, 2016

« 1 … 3 4 5 6 7 »